HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 02-19-2015, 02:25 AM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Lightbulb can NSAIDs prevent breast cancer brain mets?

J Biol Chem. 2015 Feb 17. pii: jbc.M114.602185. [Epub ahead of print]
Roles of the cyclooxygenase 2-matrix metalloproteinase 1 pathway in brain metastasis of breast cancer.
Wu K1, Fukuda K2, Xing F1, Zhang Y3, Sharma S1, Liu Y1, Chan M1, Zhou X1, Qasem S1, Pochampally R3, Mo YY3, Watabe K4.
Author information
Abstract
Brain is one of the major sites of metastasis in breast cancer; however, the pathological mechanism of brain metastasis is poorly understood. One of critical rate limiting steps of brain metastasis is the breaching the blood-brain barrier (BBB) which acts as a selective interface between the circulation and the central nervous system, and this process is considered to involve tumor-secreted proteinases. We analyzed clinical significance of 21 matrix metalloproteinases on brain metastasis-free survival of breast cancer followed by verification in brain metastatic cell lines and found that only MMP1 is significantly correlated with brain metastasis. We have shown that MMP1 is highly expressed in brain metastatic cells and is capable of degrading Claudin and Occludin but not Zo-1 that are key components of BBB. Knockdown of MMP1 in brain metastatic cells significantly suppressed their ability of brain metastasis in vivo, while ectopic expression of MMP1 significantly increased the brain metastatic ability of the cells that are not brain metastatic. We also found that COX2 was highly up-regulated in brain metastatic cells and that COX2-induced prostaglandins (PGs) were directly able to promote the expression of MMP1 followed by augmenting brain metastasis. Furthermore, we found that COX2 and prostaglandin were able to activate astrocytes to release Chemokine (C-C motif) ligand 7 (CCL7) which in turn promoted self-renewal of tumor initiating cells in the brain and that knockdown of COX2 significantly reduced the brain metastatic ability of tumor cells. Our results suggest the COX2-MMP1/CCL7 axis as a novel therapeutic target for brain metastasis.
Copyright © 2015, The American Society for Biochemistry and Molecular Biology.
KEYWORDS:
astrocyte; blood-brain barrier (BBB); brain; breast cancer; cancer initiating cell; cyclooxygenase (COX); matrix metalloproteinase (MMP); tumor metastasis
PMID: 25691572
Lani is offline   Reply With Quote
Old 02-19-2015, 03:21 AM   #2
donocco
Senior Member
 
Join Date: Oct 2013
Posts: 474
Re: can NSAIDs prevent breast cancer brain mets?

Very Interesting. Way back in the 1990s there was an article in the American Journal of Epidemiology that showd in one experiment women who took at least 4 Motrin tablets (Ibuprofen) weekly had a 50% decrease in breast cancer incidence. Now its pointing to brain mets.

Of all the common NSAIDS I think Indomethacin penetrates into the brain the best, but most of them must as they lower fever by acting in the brain.

Paul
donocco is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 07:00 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter